{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:02:33Z","timestamp":1788966153172,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11064-021-03519-3","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:03:41Z","timestamp":1643587421000},"page":"1255-1268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3496-8250","authenticated-orcid":false,"given":"Baruh","family":"Polis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Squillario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolluru D.","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Assa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham O.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"3519_CR1","doi-asserted-by":"publisher","unstructured":"2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. https:\/\/doi.org\/10.1002\/alz.12068.","DOI":"10.1002\/alz.12068"},{"issue":"5800","key":"3519_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG (2006) A century of Alzheimer\u2019s disease. Science 314(5800):777\u2013781. https:\/\/doi.org\/10.1126\/science.1132814","journal-title":"Science"},{"key":"3519_CR3","doi-asserted-by":"crossref","unstructured":"Polis B, Samson AO (2019) A new perspective on Alzheimer's disease as a brain expression of a complex metabolic disorder. In: Wisniewski T (ed) Alzheimer's disease. Brisbane(AU)","DOI":"10.15586\/alzheimersdisease.2019.ch1"},{"issue":"19","key":"3519_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10194360","volume":"10","author":"I Avitan","year":"2021","unstructured":"Avitan I, Halperin Y, Saha T, Bloch N, Atrahimovich D, Polis B et al (2021) Towards a consensus on Alzheimer\u2019s disease comorbidity? J Clin Med. 10(19):10. https:\/\/doi.org\/10.3390\/jcm10194360","journal-title":"J Clin Med."},{"key":"3519_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195. https:\/\/doi.org\/10.1196\/annals.1427.007","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"3519_CR6","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36(7):1238\u20131248","journal-title":"J Nucl Med"},{"issue":"1","key":"3519_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol 42(1):85\u201394. https:\/\/doi.org\/10.1002\/ana.410420114","journal-title":"Ann Neurol"},{"issue":"4","key":"3519_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A et al (2012) Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122(4):1316\u20131338. https:\/\/doi.org\/10.1172\/JCI59903","journal-title":"J Clin Invest"},{"issue":"6","key":"3519_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM de la Monte","year":"2008","unstructured":"de la Monte SM, Wands JR (2008) Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2(6):1101\u20131113. https:\/\/doi.org\/10.1177\/193229680800200619","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"3519_CR10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98(4):2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"issue":"2","key":"3519_CR11","doi-asserted-by":"publisher","first-page":"C125","DOI":"10.1152\/ajpcell.00240.2017","volume":"315","author":"SM Gray","year":"2018","unstructured":"Gray SM, Barrett EJ (2018) Insulin transport into the brain. Am J Physiol Cell Physiol 315(2):C125\u2013C136. https:\/\/doi.org\/10.1152\/ajpcell.00240.2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"3519_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0304-3940(96)12845-7","volume":"213","author":"M Kobayashi","year":"1996","unstructured":"Kobayashi M, Nikami H, Morimatsu M, Saito M (1996) Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain. Neurosci Lett 213(2):103\u2013106. https:\/\/doi.org\/10.1016\/0304-3940(96)12845-7","journal-title":"Neurosci Lett"},{"issue":"2","key":"3519_CR13","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1152\/ajpendo.90388.2008","volume":"295","author":"IA Simpson","year":"2008","unstructured":"Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ (2008) The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 295(2):E242\u2013E253. https:\/\/doi.org\/10.1152\/ajpendo.90388.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Pt 2","key":"3519_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/bj3010379","volume":"301","author":"F Maher","year":"1994","unstructured":"Maher F, Simpson IA (1994) The GLUT3 glucose transporter is the predominant isoform in primary cultured neurons: assessment by biosynthetic and photoaffinity labelling. Biochem J 301(Pt 2):379\u2013384. https:\/\/doi.org\/10.1042\/bj3010379","journal-title":"Biochem J"},{"issue":"Pt 3","key":"3519_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1042\/bj3150827","volume":"315","author":"F Maher","year":"1996","unstructured":"Maher F, Davies-Hill TM, Simpson IA (1996) Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem J 315(Pt 3):827\u2013831. https:\/\/doi.org\/10.1042\/bj3150827","journal-title":"Biochem J"},{"key":"3519_CR16","doi-asserted-by":"publisher","first-page":"626636","DOI":"10.3389\/fnins.2021.626636","volume":"15","author":"N Kyrtata","year":"2021","unstructured":"Kyrtata N, Emsley HCA, Sparasci O, Parkes LM, Dickie BR (2021) A systematic review of glucose transport alterations in Alzheimer\u2019s disease. Front Neurosci 15:626636. https:\/\/doi.org\/10.3389\/fnins.2021.626636","journal-title":"Front Neurosci"},{"issue":"5","key":"3519_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.410350507","volume":"35","author":"IA Simpson","year":"1994","unstructured":"Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease. Ann Neurol 35(5):546\u2013551. https:\/\/doi.org\/10.1002\/ana.410350507","journal-title":"Ann Neurol"},{"issue":"1","key":"3519_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(sici)1098-1136(199709)21:1<2::aid-glia2>3.0.co;2-c","volume":"21","author":"SJ Vannucci","year":"1997","unstructured":"Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21(1):2\u201321. https:\/\/doi.org\/10.1002\/(sici)1098-1136(199709)21:1%3c2::aid-glia2%3e3.0.co;2-c","journal-title":"Glia"},{"issue":"2","key":"3519_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","volume":"72","author":"M Lesort","year":"1999","unstructured":"Lesort M, Jope RS, Johnson GV (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72(2):576\u2013584. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0720576.x","journal-title":"J Neurochem"},{"issue":"2","key":"3519_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0306-4522(00)00200-1","volume":"99","author":"M Lesort","year":"2000","unstructured":"Lesort M, Johnson GV (2000) Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience 99(2):305\u2013316. https:\/\/doi.org\/10.1016\/s0306-4522(00)00200-1","journal-title":"Neuroscience"},{"issue":"9","key":"3519_CR21","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1073\/pnas.0308724101","volume":"101","author":"M Schubert","year":"2004","unstructured":"Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D et al (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101(9):3100\u20133105. https:\/\/doi.org\/10.1073\/pnas.0308724101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3519_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(95)12009-s","volume":"199","author":"M Tanaka","year":"1995","unstructured":"Tanaka M, Sawada M, Yoshida S, Hanaoka F, Marunouchi T (1995) Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures. Neurosci Lett 199(1):37\u201340. https:\/\/doi.org\/10.1016\/0304-3940(95)12009-s","journal-title":"Neurosci Lett"},{"issue":"4","key":"3519_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.bbrc.2015.09.006","volume":"466","author":"M Umeda","year":"2015","unstructured":"Umeda M, Hiramoto M, Watanabe A, Tsunoda N, Imai T (2015) Arginine-induced insulin secretion in endoplasmic reticulum. Biochem Biophys Res Commun 466(4):717\u2013722. https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.006","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3519_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/eje.0.1400087","volume":"140","author":"P Thams","year":"1999","unstructured":"Thams P, Capito K (1999) L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Eur J Endocrinol 140(1):87\u201393. https:\/\/doi.org\/10.1530\/eje.0.1400087","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"3519_CR25","doi-asserted-by":"publisher","first-page":"E800","DOI":"10.1152\/ajpendo.00337.2014","volume":"307","author":"V Leiss","year":"2014","unstructured":"Leiss V, Flockerzie K, Novakovic A, Rath M, Schonsiegel A, Birnbaumer L et al (2014) Insulin secretion stimulated by L-arginine and its metabolite L-ornithine depends on Galpha(i2). Am J Physiol Endocrinol Metab 307(9):E800\u2013E812. https:\/\/doi.org\/10.1152\/ajpendo.00337.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"3519_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/1389203717666160627074017","volume":"18","author":"S Hu","year":"2017","unstructured":"Hu S, Han M, Rezaei A, Li D, Wu G, Ma X (2017) L-Arginine modulates glucose and lipid metabolism in obesity and diabetes. Curr Protein Pept Sci 18(6):599\u2013608. https:\/\/doi.org\/10.2174\/1389203717666160627074017","journal-title":"Curr Protein Pept Sci"},{"issue":"6","key":"3519_CR27","doi-asserted-by":"publisher","first-page":"e66735","DOI":"10.1371\/journal.pone.0066735","volume":"8","author":"D Peters","year":"2013","unstructured":"Peters D, Berger J, Langnaese K, Derst C, Madai VI, Krauss M et al (2013) Arginase and arginine decarboxylase\u2014where do the putative gate keepers of polyamine synthesis reside in rat brain? PLoS ONE 8(6):e66735. https:\/\/doi.org\/10.1371\/journal.pone.0066735","journal-title":"PLoS ONE"},{"key":"3519_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/tnsci-2018-0009","volume":"9","author":"G Fonar","year":"2018","unstructured":"Fonar G, Polis B, Meirson T, Maltsev A, Elliott E, Samson AO (2018) Intracerebroventricular administration of L-arginine improves spatial memory acquisition in triple transgenic mice via reduction of oxidative stress and apoptosis. Transl Neurosci 9:43\u201353. https:\/\/doi.org\/10.1515\/tnsci-2018-0009","journal-title":"Transl Neurosci"},{"issue":"4","key":"3519_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","volume":"15","author":"B Polis","year":"2018","unstructured":"Polis B, Srikanth KD, Elliott E, Gil-Henn H, Samson AO (2018) L-norvaline reverses cognitive decline and synaptic loss in a murine model of Alzheimer\u2019s Disease. Neurotherapeutics 15(4):1036\u20131054. https:\/\/doi.org\/10.1007\/s13311-018-0669-5","journal-title":"Neurotherapeutics"},{"issue":"15","key":"3519_CR30","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1523\/JNEUROSCI.4668-14.2015","volume":"35","author":"MJ Kan","year":"2015","unstructured":"Kan MJ, Lee JE, Wilson JG, Everhart AL, Brown CM, Hoofnagle AN et al (2015) Arginine deprivation and immune suppression in a mouse model of Alzheimer\u2019s disease. J Neurosci 35(15):5969\u20135982. https:\/\/doi.org\/10.1523\/JNEUROSCI.4668-14.2015","journal-title":"J Neurosci"},{"issue":"9","key":"3519_CR31","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.4103\/1673-5374.255980","volume":"14","author":"B Polis","year":"2019","unstructured":"Polis B, Srikanth KD, Gurevich V, Gil-Henn H, Samson AO (2019) L-Norvaline, a new therapeutic agent against Alzheimer\u2019s disease. Neural Regen Res 14(9):1562\u20131572. https:\/\/doi.org\/10.4103\/1673-5374.255980","journal-title":"Neural Regen Res"},{"key":"3519_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031133","author":"B Polis","year":"2020","unstructured":"Polis B, Srikanth KD, Gurevich V, Bloch N, Gil-Henn H, Samson AO (2020) Arginase inhibition supports survival and differentiation of neuronal precursors in adult Alzheimer\u2019s disease mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21031133","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3519_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39(3):409\u2013421. https:\/\/doi.org\/10.1016\/s0896-6273(03)00434-3","journal-title":"Neuron"},{"key":"3519_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmed.2019.00071","volume":"6","author":"C Bouter","year":"2019","unstructured":"Bouter C, Bouter Y (2019) (18)F-FDG-PET in mouse models of Alzheimer\u2019s disease. Front Med (Lausanne) 6:71. https:\/\/doi.org\/10.3389\/fmed.2019.00071","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"3519_CR35","doi-asserted-by":"publisher","first-page":"e69830","DOI":"10.1371\/journal.pone.0069830","volume":"8","author":"H Sancheti","year":"2013","unstructured":"Sancheti H, Akopian G, Yin F, Brinton RD, Walsh JP, Cadenas E (2013) Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer\u2019s disease. PLoS ONE 8(7):e69830. https:\/\/doi.org\/10.1371\/journal.pone.0069830","journal-title":"PLoS ONE"},{"issue":"6","key":"3519_CR36","first-page":"999","volume":"47","author":"BJ Fueger","year":"2006","unstructured":"Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D et al (2006) Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 47(6):999\u20131006","journal-title":"J Nucl Med"},{"key":"3519_CR37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bbi.2019.05.041","volume":"80","author":"B Bellaver","year":"2019","unstructured":"Bellaver B, Rocha AS, Souza DG, Leffa DT, De Bastiani MA, Schu G et al (2019) Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivity. Brain Behav Immun 80:879\u2013888. https:\/\/doi.org\/10.1016\/j.bbi.2019.05.041","journal-title":"Brain Behav Immun"},{"issue":"W1","key":"3519_CR38","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Vasaikar S, Shi Z, Greer M, Zhang B (2017) WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res 45(W1):W130\u2013W137. https:\/\/doi.org\/10.1093\/nar\/gkx356","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3519_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3519_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.18502\/ajmb.v13i1.4579","volume":"13","author":"H Dixit","year":"2021","unstructured":"Dixit H, Kumar CS, Chaudhary R, Thaker D, Gadewal N, Dasgupta D (2021) Role of phosphorylation and hyperphosphorylation of tau in its interaction with betaalpha dimeric tubulin studied from a bioinformatics perspective. Avicenna J Med Biotechnol 13(1):24\u201334. https:\/\/doi.org\/10.18502\/ajmb.v13i1.4579","journal-title":"Avicenna J Med Biotechnol"},{"key":"3519_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2121-10-81","volume":"10","author":"HJ He","year":"2009","unstructured":"He HJ, Wang XS, Pan R, Wang DL, Liu MN, He RQ (2009) The proline-rich domain of tau plays a role in interactions with actin. BMC Cell Biol 10:81. https:\/\/doi.org\/10.1186\/1471-2121-10-81","journal-title":"BMC Cell Biol"},{"issue":"Pt 3","key":"3519_CR42","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1042\/0264-6021:3570759","volume":"357","author":"J Eidenmuller","year":"2001","unstructured":"Eidenmuller J, Fath T, Maas T, Pool M, Sontag E, Brandt R (2001) Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J 357(Pt 3):759\u2013767. https:\/\/doi.org\/10.1042\/0264-6021:3570759","journal-title":"Biochem J"},{"key":"3519_CR43","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180127","author":"H Li","year":"2018","unstructured":"Li H, Ye D, Xie W, Hua F, Yang Y, Wu J et al (2018) Defect of branched-chain amino acid metabolism promotes the development of Alzheimer\u2019s disease by targeting the mTOR signaling. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20180127","journal-title":"Biosci Rep"},{"issue":"2","key":"3519_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondragon-Rodriguez","year":"2014","unstructured":"Mondragon-Rodriguez S, Perry G, Luna-Munoz J, Acevedo-Aquino MC, Williams S (2014) Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome. Neuropathol Appl Neurobiol 40(2):121\u2013135. https:\/\/doi.org\/10.1111\/nan.12084","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"3519_CR45","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1021\/bi9724265","volume":"37","author":"H Yanagawa","year":"1998","unstructured":"Yanagawa H, Chung SH, Ogawa Y, Sato K, Shibata-Seki T, Masai J et al (1998) Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer\u2019s paired helical filament formation in vitro. Biochemistry 37(7):1979\u20131988. https:\/\/doi.org\/10.1021\/bi9724265","journal-title":"Biochemistry"},{"issue":"8","key":"3519_CR46","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4103\/1673-5374.274328","volume":"15","author":"B Polis","year":"2020","unstructured":"Polis B, Samson AO (2020) Role of the metabolism of branched-chain amino acids in the development of Alzheimer\u2019s disease and other metabolic disorders. Neural Regen Res 15(8):1460\u20131470. https:\/\/doi.org\/10.4103\/1673-5374.274328","journal-title":"Neural Regen Res"},{"issue":"9","key":"3519_CR47","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1074\/jbc.273.9.4982","volume":"273","author":"J Davoodi","year":"1998","unstructured":"Davoodi J, Drown PM, Bledsoe RK, Wallin R, Reinhart GD, Hutson SM (1998) Overexpression and characterization of the human mitochondrial and cytosolic branched-chain aminotransferases. J Biol Chem 273(9):4982\u20134989. https:\/\/doi.org\/10.1074\/jbc.273.9.4982","journal-title":"J Biol Chem"},{"issue":"6","key":"3519_CR48","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnen\/nlw026","volume":"75","author":"A Serrano-Pozo","year":"2016","unstructured":"Serrano-Pozo A, Qian J, Muzikansky A, Monsell SE, Montine TJ, Frosch MP et al (2016) Thal amyloid stages do not significantly impact the correlation between neuropathological change and cognition in the Alzheimer disease continuum. J Neuropathol Exp Neurol 75(6):516\u2013526. https:\/\/doi.org\/10.1093\/jnen\/nlw026","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3519_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/JAD-190220","volume":"70","author":"M Khosravi","year":"2019","unstructured":"Khosravi M, Peter J, Wintering NA, Serruya M, Shamchi SP, Werner TJ et al (2019) 18F-FDG is a superior indicator of cognitive performance compared to 18F-Florbetapir in Alzheimer\u2019s disease and mild cognitive impairment evaluation: a global quantitative analysis. J Alzheimers Dis 70(4):1197\u20131207. https:\/\/doi.org\/10.3233\/JAD-190220","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3519_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.0959-9673.2005.00429.x","volume":"86","author":"HG Lee","year":"2005","unstructured":"Lee HG, Castellani RJ, Zhu X, Perry G, Smith MA (2005) Amyloid-beta in Alzheimer\u2019s disease: the horse or the cart? Pathogenic or protective? Int J Exp Pathol 86(3):133\u2013138. https:\/\/doi.org\/10.1111\/j.0959-9673.2005.00429.x","journal-title":"Int J Exp Pathol"},{"issue":"7","key":"3519_CR51","doi-asserted-by":"publisher","first-page":"10770","DOI":"10.18632\/aging.202928","volume":"13","author":"B Polis","year":"2021","unstructured":"Polis B, Karasik D, Samson AO (2021) Alzheimer\u2019s disease as a chronic maladaptive polyamine stress response. Aging (Albany NY) 13(7):10770\u201310795. https:\/\/doi.org\/10.18632\/aging.202928","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"3519_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/1567205011666140505111354","volume":"11","author":"IR Macdonald","year":"2014","unstructured":"Macdonald IR, DeBay DR, Reid GA, O\u2019Leary TP, Jollymore CT, Mawko G et al (2014) Early detection of cerebral glucose uptake changes in the 5XFAD mouse. Curr Alzheimer Res 11(5):450\u2013460. https:\/\/doi.org\/10.2174\/1567205011666140505111354","journal-title":"Curr Alzheimer Res"},{"key":"3519_CR53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","volume":"10","author":"C Bouter","year":"2018","unstructured":"Bouter C, Henniges P, Franke TN, Irwin C, Sahlmann CO, Sichler ME et al (2018) (18)F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer\u2019s disease. Front Aging Neurosci 10:425. https:\/\/doi.org\/10.3389\/fnagi.2018.00425","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3519_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000491661","volume":"48","author":"Q Wang","year":"2018","unstructured":"Wang Q, Lv C, Sun Y, Han X, Wang S, Mao Z et al (2018) The role of alpha-lipoic acid in the pathomechanism of acute ischemic stroke. Cell Physiol Biochem 48(1):42\u201353. https:\/\/doi.org\/10.1159\/000491661","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"3519_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s001250050047","volume":"43","author":"K Yaworsky","year":"2000","unstructured":"Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A (2000) Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43(3):294\u2013303. https:\/\/doi.org\/10.1007\/s001250050047","journal-title":"Diabetologia"},{"key":"3519_CR56","doi-asserted-by":"publisher","first-page":"195271","DOI":"10.1155\/2011\/195271","volume":"2011","author":"GN Dakhale","year":"2011","unstructured":"Dakhale GN, Chaudhari HV, Shrivastava M (2011) Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci 2011:195271. https:\/\/doi.org\/10.1155\/2011\/195271","journal-title":"Adv Pharmacol Sci"},{"key":"3519_CR57","doi-asserted-by":"publisher","first-page":"2673076","DOI":"10.1155\/2018\/2673076","volume":"2018","author":"D Atrahimovich","year":"2018","unstructured":"Atrahimovich D, Samson AO, Khattib A, Vaya J, Khatib S (2018) Punicalagin decreases serum glucose levels and increases PON1 activity and HDL anti-inflammatory values in Balb\/c mice fed a high-fat diet. Oxid Med Cell Longev 2018:2673076. https:\/\/doi.org\/10.1155\/2018\/2673076","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"3519_CR58","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00726-020-02881-w","volume":"52","author":"CJ Malpica-Nieves","year":"2020","unstructured":"Malpica-Nieves CJ, Rivera-Aponte DE, Tejeda-Bayron FA, Mayor AM, Phanstiel O, Veh RW et al (2020) The involvement of polyamine uptake and synthesis pathways in the proliferation of neonatal astrocytes. Amino Acids 52(8):1169\u20131180. https:\/\/doi.org\/10.1007\/s00726-020-02881-w","journal-title":"Amino Acids"},{"key":"3519_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainres.2010.05.084","volume":"1347","author":"RM Nicholson","year":"2010","unstructured":"Nicholson RM, Kusne Y, Nowak LA, LaFerla FM, Reiman EM, Valla J (2010) Regional cerebral glucose uptake in the 3xTG model of Alzheimer\u2019s disease highlights common regional vulnerability across AD mouse models. Brain Res 1347:179\u2013185. https:\/\/doi.org\/10.1016\/j.brainres.2010.05.084","journal-title":"Brain Res"},{"issue":"3","key":"3519_CR60","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/acel.12057","volume":"12","author":"A Caccamo","year":"2013","unstructured":"Caccamo A, Magri A, Medina DX, Wisely EV, Lopez-Aranda MF, Silva AJ et al (2013) mTOR regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies. Aging Cell 12(3):370\u2013380. https:\/\/doi.org\/10.1111\/acel.12057","journal-title":"Aging Cell"},{"issue":"5","key":"3519_CR61","doi-asserted-by":"publisher","first-page":"e62459","DOI":"10.1371\/journal.pone.0062459","volume":"8","author":"S Ozcelik","year":"2013","unstructured":"Ozcelik S, Fraser G, Castets P, Schaeffer V, Skachokova Z, Breu K et al (2013) Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS ONE 8(5):e62459. https:\/\/doi.org\/10.1371\/journal.pone.0062459","journal-title":"PLoS ONE"},{"issue":"1","key":"3519_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.febslet.2005.11.059","volume":"580","author":"JJ Pei","year":"2006","unstructured":"Pei JJ, An WL, Zhou XW, Nishimura T, Norberg J, Benedikz E et al (2006) P70 S6 kinase mediates tau phosphorylation and synthesis. FEBS Lett 580(1):107\u2013114. https:\/\/doi.org\/10.1016\/j.febslet.2005.11.059","journal-title":"FEBS Lett"},{"issue":"41","key":"3519_CR63","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1523\/JNEUROSCI.2781-15.2015","volume":"35","author":"A Caccamo","year":"2015","unstructured":"Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L et al (2015) Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer\u2019s Disease. J Neurosci 35(41):14042\u201314056. https:\/\/doi.org\/10.1523\/JNEUROSCI.2781-15.2015","journal-title":"J Neurosci"},{"key":"3519_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2261-9-12","volume":"9","author":"XF Ming","year":"2009","unstructured":"Ming XF, Rajapakse AG, Carvas JM, Ruffieux J, Yang Z (2009) Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline. BMC Cardiovasc Disord 9:12. https:\/\/doi.org\/10.1186\/1471-2261-9-12","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"3519_CR65","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1074\/jbc.273.3.1496","volume":"273","author":"KN Dalby","year":"1998","unstructured":"Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P (1998) Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a\/p90rsk that are inducible by MAPK. J Biol Chem 273(3):1496\u20131505. https:\/\/doi.org\/10.1074\/jbc.273.3.1496","journal-title":"J Biol Chem"},{"issue":"12","key":"3519_CR66","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1128\/MCB.21.12.3947-3958.2001","volume":"21","author":"L Simpson","year":"2001","unstructured":"Simpson L, Li J, Liaw D, Hennessy I, Oliner J, Christians F et al (2001) PTEN expression causes feedback upregulation of insulin receptor substrate 2. Mol Cell Biol 21(12):3947\u20133958. https:\/\/doi.org\/10.1128\/MCB.21.12.3947-3958.2001","journal-title":"Mol Cell Biol"},{"issue":"11","key":"3519_CR67","doi-asserted-by":"publisher","first-page":"C874","DOI":"10.1152\/ajpcell.00374.2015","volume":"310","author":"M Moberg","year":"2016","unstructured":"Moberg M, Apro W, Ekblom B, van Hall G, Holmberg HC, Blomstrand E (2016) Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise. Am J Physiol Cell Physiol 310(11):C874\u2013C884. https:\/\/doi.org\/10.1152\/ajpcell.00374.2015","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"3519_CR68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2337\/db07-0843","volume":"57","author":"SL McGee","year":"2008","unstructured":"McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, Kemp BE et al (2008) AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57(4):860\u2013867. https:\/\/doi.org\/10.2337\/db07-0843","journal-title":"Diabetes"},{"issue":"3","key":"3519_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/JME-12-0095","volume":"49","author":"S Raichur","year":"2012","unstructured":"Raichur S, Teh SH, Ohwaki K, Gaur V, Long YC, Hargreaves M et al (2012) Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells. J Mol Endocrinol 49(3):203\u2013211. https:\/\/doi.org\/10.1530\/JME-12-0095","journal-title":"J Mol Endocrinol"},{"key":"3519_CR70","doi-asserted-by":"publisher","first-page":"143269","DOI":"10.1155\/2011\/143269","volume":"2011","author":"K Xu","year":"2011","unstructured":"Xu K, Dai XL, Huang HC, Jiang ZF (2011) Targeting HDACs: a promising therapy for Alzheimer\u2019s disease. Oxid Med Cell Longev 2011:143269. https:\/\/doi.org\/10.1155\/2011\/143269","journal-title":"Oxid Med Cell Longev"},{"key":"3519_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"SS Yang","year":"2017","unstructured":"Yang SS, Zhang R, Wang G, Zhang YF (2017) The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener 6:19. https:\/\/doi.org\/10.1186\/s40035-017-0089-1","journal-title":"Transl Neurodegener"},{"issue":"Pt 11","key":"3519_CR72","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1242\/jcs.147553","volume":"127","author":"K Shah","year":"2014","unstructured":"Shah K, Lahiri DK (2014) Cdk5 activity in the brain - multiple paths of regulation. J Cell Sci 127(Pt 11):2391\u20132400. https:\/\/doi.org\/10.1242\/jcs.147553","journal-title":"J Cell Sci"},{"issue":"8","key":"3519_CR73","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10571-009-9410-6","volume":"29","author":"J Kanungo","year":"2009","unstructured":"Kanungo J, Zheng YL, Amin ND, Pant HC (2009) Targeting Cdk5 activity in neuronal degeneration and regeneration. Cell Mol Neurobiol 29(8):1073\u20131080. https:\/\/doi.org\/10.1007\/s10571-009-9410-6","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"3519_CR74","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s0896-6273(03)00259-9","volume":"38","author":"W Noble","year":"2003","unstructured":"Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J et al (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38(4):555\u2013565. https:\/\/doi.org\/10.1016\/s0896-6273(03)00259-9","journal-title":"Neuron"},{"issue":"18","key":"3519_CR75","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/hmg\/ddz120","volume":"28","author":"T Saito","year":"2019","unstructured":"Saito T, Oba T, Shimizu S, Asada A, Iijima KM, Ando K (2019) Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262. Hum Mol Genet 28(18):3062\u20133071. https:\/\/doi.org\/10.1093\/hmg\/ddz120","journal-title":"Hum Mol Genet"},{"issue":"10","key":"3519_CR76","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1299","volume":"11","author":"FY Wei","year":"2005","unstructured":"Wei FY, Nagashima K, Ohshima T, Saheki Y, Lu YF, Matsushita M et al (2005) Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 11(10):1104\u20131108. https:\/\/doi.org\/10.1038\/nm1299","journal-title":"Nat Med"},{"key":"3519_CR77","doi-asserted-by":"publisher","first-page":"116979","DOI":"10.1016\/j.lfs.2019.116979","volume":"238","author":"H Wu","year":"2019","unstructured":"Wu H, Wu ZG, Shi WJ, Gao H, Wu HH, Bian F et al (2019) Effects of progesterone on glucose uptake in neurons of Alzheimer\u2019s disease animals and cell models. Life Sci 238:116979. https:\/\/doi.org\/10.1016\/j.lfs.2019.116979","journal-title":"Life Sci"},{"issue":"3","key":"3519_CR78","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12264-013-1298-y","volume":"29","author":"X Li","year":"2013","unstructured":"Li X, Han H, Hou R, Wei L, Wang G, Li C et al (2013) Progesterone treatment before experimental hypoxia-ischemia enhances the expression of glucose transporter proteins GLUT1 and GLUT3 in neonatal rats. Neurosci Bull 29(3):287\u2013294. https:\/\/doi.org\/10.1007\/s12264-013-1298-y","journal-title":"Neurosci Bull"},{"issue":"12","key":"3519_CR79","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1002\/j.1460-2075.1991.tb04954.x","volume":"10","author":"A Guiochon-Mantel","year":"1991","unstructured":"Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E (1991) Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 10(12):3851\u20133859","journal-title":"EMBO J"},{"issue":"1\u20132","key":"3519_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mce.2011.09.017","volume":"357","author":"CR Hagan","year":"2012","unstructured":"Hagan CR, Daniel AR, Dressing GE, Lange CA (2012) Role of phosphorylation in progesterone receptor signaling and specificity. Mol Cell Endocrinol 357(1\u20132):43\u201349. https:\/\/doi.org\/10.1016\/j.mce.2011.09.017","journal-title":"Mol Cell Endocrinol"},{"key":"3519_CR81","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191","author":"J Boucher","year":"2014","unstructured":"Boucher J, Kleinridders A, Kahn CR (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a009191","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03519-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:16:37Z","timestamp":1648577797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03519-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3519"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03519-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"29 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Bar-Ilan University Animal Care and Use Committee (approval No. 82\u201310-2017) on October 1, 2017.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}